Impact of interventions to reduce Alzheimer's disease pathology on the prevalence of dementia in the oldest-old

被引:34
作者
Brookmeyer, Ron [1 ]
Kawas, Claudia H. [2 ,3 ,4 ]
Abdallah, Nada [1 ]
Paganini-Hill, Annlia [2 ]
Kim, Ronald C. [5 ]
Corrada, Maria M. [2 ,4 ,6 ]
机构
[1] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA
[2] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA
[3] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA
[4] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA
[5] Univ Calif Irvine, Med Ctr, Dept Pathol, Orange, CA USA
[6] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; Dementia; Intervention; Oldest-old; Pathology; Prediction; Prevalence; Prevention; NEUROPATHOLOGIC ASSESSMENT; NATIONAL INSTITUTE; AGE; COMMON; MODEL; RISK;
D O I
10.1016/j.jalz.2016.01.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The number of persons aged >90 years will grow significantly in coming decades. This group has the highest rates of dementia, most commonly Alzheimer's disease (AD). Methods: Using The 90+ Study, we developed a statistical model for dementia risk based on brain pathologies. Intervention scenarios which reduce or eliminate AD pathology were considered, and the numbers of dementia cases among the U.S. oldest-old that could be prevented were estimated. Results: The U.S. dementia prevalence among the oldest-old will increase from 1.35 million in 2015 to 4.72 million in 2050. If interventions eliminate AD pathology, dementia prevalence would be reduced by approximately 50%, averting nearly 2.4 million cases in 2050. However, large numbers of dementia cases would still remain. Discussion: Reducing AD pathology would significantly decrease the public health burden of dementia. However, other interventions are needed to address the burden associated with other dementing pathologies prevalent in the oldest-old. (C) 2016 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 34 条
  • [31] ESTIMATION AND INTERPRETATION OF ATTRIBUTABLE RISK IN HEALTH RESEARCH
    WALTER, SD
    [J]. BIOMETRICS, 1976, 32 (04) : 829 - 849
  • [32] Do current therapeutic anti-Aβ antibodies for Alzheimer's disease engage the target?
    Watt, Andrew D.
    Crespi, Gabriela A. N.
    Down, Russell A.
    Ascher, David B.
    Gunn, Adam
    Perez, Keyla A.
    McLean, Catriona A.
    Villemagne, Victor L.
    Parker, Michael W.
    Barnham, Kevin J.
    Miles, Luke A.
    [J]. ACTA NEUROPATHOLOGICA, 2014, 127 (06) : 803 - 810
  • [33] Recent clinical-pathologic research on the causes of dementia in late life: Update from the Honolulu-Asia Aging Study
    White, L
    Small, BJ
    Petrovitch, H
    Ross, GW
    Masaki, K
    Abbott, RD
    Hardman, J
    Davis, D
    Nelson, J
    Markesbery, W
    [J]. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2005, 18 (04) : 224 - 227
  • [34] Cerebrovascular pathology and dementia in autopsied Honolulu-Asia aging study participants
    White, L
    Petrovitch, H
    Hardman, J
    Nelson, J
    Davis, DG
    Ross, GW
    Masaki, K
    Launer, L
    Markesbery, WR
    [J]. ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY, 2002, 977 : 9 - 23